EA200000918A1 - Способ изготовления глазных препаратов местного применения без общих действий - Google Patents

Способ изготовления глазных препаратов местного применения без общих действий

Info

Publication number
EA200000918A1
EA200000918A1 EA200000918A EA200000918A EA200000918A1 EA 200000918 A1 EA200000918 A1 EA 200000918A1 EA 200000918 A EA200000918 A EA 200000918A EA 200000918 A EA200000918 A EA 200000918A EA 200000918 A1 EA200000918 A1 EA 200000918A1
Authority
EA
Eurasian Patent Office
Prior art keywords
drugs
timolol
clonidine
preparations
topically
Prior art date
Application number
EA200000918A
Other languages
English (en)
Russian (ru)
Inventor
Бакулиш Мафатлал Хамар
Original Assignee
Бакулиш Мафатлал Хамар
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бакулиш Мафатлал Хамар filed Critical Бакулиш Мафатлал Хамар
Publication of EA200000918A1 publication Critical patent/EA200000918A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EA200000918A 1999-02-03 2000-02-02 Способ изготовления глазных препаратов местного применения без общих действий EA200000918A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN90BO1999 IN185228B (sl) 1999-02-03 1999-02-03
PCT/IN2000/000008 WO2000049990A2 (en) 1999-02-03 2000-02-02 The process for manufacturing topical ophthalmic preparations without systemic effects

Publications (1)

Publication Number Publication Date
EA200000918A1 true EA200000918A1 (ru) 2001-10-22

Family

ID=11077485

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000918A EA200000918A1 (ru) 1999-02-03 2000-02-02 Способ изготовления глазных препаратов местного применения без общих действий

Country Status (11)

Country Link
EP (1) EP1139970A2 (sl)
AP (1) AP2000001977A0 (sl)
AU (1) AU4429100A (sl)
BR (1) BR0004530A (sl)
CA (1) CA2326690A1 (sl)
EA (1) EA200000918A1 (sl)
ID (1) ID28121A (sl)
IL (1) IL138824A0 (sl)
IN (1) IN185228B (sl)
WO (1) WO2000049990A2 (sl)
ZA (1) ZA200006252B (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
AU2005220199B2 (en) * 2000-07-14 2007-03-08 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
BR0109317A (pt) * 2000-07-14 2003-06-17 Allergan Inc Composições contendo componentes agonistas alfa-2-adrenérgicos
DE10132876A1 (de) * 2001-07-06 2003-01-30 Medproject Pharma Entwicklungs Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
EP2481412B1 (en) 2004-05-25 2017-09-27 Galderma Pharma S.A. Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
EP2329849B1 (en) 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
FR2977493B1 (fr) 2011-07-05 2014-02-14 Galderma Res & Dev Nouvelle composition anesthesique stable pour la reduction des reactions cutanees
BR112015019546A2 (pt) * 2013-02-15 2017-07-18 Allergan Inc implante de distribuição de drogas prolongado
WO2014150899A1 (en) * 2013-03-15 2014-09-25 Chapin Matthew J Topical ophthalmic formulations for treating migraine
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
WO2016196367A1 (en) 2015-05-29 2016-12-08 Sydnexis, Inc. D2o stabilized pharmaceutical formulations
GB202110420D0 (en) * 2021-07-20 2021-09-01 Rosemont Pharmaceuticals Ltd Liquid pharmaceutical composition of clonidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
DD294174A5 (de) * 1990-05-04 1991-09-26 Sigrid Keipert Ophthalmika mit retardwirkung und ein neues verfahren zu ihrer herstellung
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
FR2679773A1 (fr) * 1991-07-30 1993-02-05 Merck Sharp & Dohme Preparation ophtalmique contenant un agent osmotique acceptable antimicrobien.
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Also Published As

Publication number Publication date
IL138824A0 (en) 2001-10-31
CA2326690A1 (en) 2000-08-31
ID28121A (id) 2001-05-03
AP2000001977A0 (en) 2000-12-31
BR0004530A (pt) 2001-04-03
ZA200006252B (en) 2001-11-29
WO2000049990A3 (en) 2001-07-26
IN185228B (sl) 2000-12-09
EP1139970A2 (en) 2001-10-10
AU4429100A (en) 2000-09-14
WO2000049990A2 (en) 2000-08-31

Similar Documents

Publication Publication Date Title
EA200000918A1 (ru) Способ изготовления глазных препаратов местного применения без общих действий
EA200800337A1 (ru) Композиция и способ введения офтальмологически активных средств
BR9812361A (pt) Uso de combinações compreendendo anti-histaminas não-sedantes e drogas alfa-adrenérgicas para o tratamento tópico de rinite/conjutivite e sintomas de infecção por vìrus, semelhante a infecção por vìrus e/ou resfriado
CA2460140A1 (en) Compositions for treatment of common cold
EP1283054A4 (en) MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF
AU2005299696B2 (en) Ophthalmic compositions and methods of using the same
JP2010132681A (ja) 向上した薬物動態特性を有する組成物
CA2381097A1 (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
WO2004041153A3 (en) Pharmaceutical composition including low dosages of desmopressin
WO2006093784A3 (en) Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents
NO20024733D0 (no) Hydrofile molekyl¶rdisperse lösninger av karvedilol
MA27734A1 (fr) DERIVES HEXAHYDROPYRAZINO [1,2-a]PYRIMIDINE-4,7-DIONE SUBSTITUES SUR L'AZOTE, METHODE POUR LEUR PRODUCTION ET LEUR UTILISATION EN TANT QUE MEDICAMENTS
BR0215238A (pt) Uso de nanopartìculas inor ânicas sintéticas como veìculos para drogas oftálmicas e óticas
BR0305628A (pt) Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
DE60325887D1 (de) Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen
ZA200201903B (en) Use of H1 antagonist and a safe steriod to treat eye conditions.
KR20020050273A (ko) 에피나스틴 함유 액제
Chow et al. Mooren's ulcer
WO2003015703A3 (en) Compositions and methods relating to novel benzodiazepine compounds and targets thereof
BR0114196A (pt) Formas polimórficas de maleato de 5-[4-[2-[n-metil-n-(2-piridil) amino]etóxi]benzil]tiazolidina-2,4-diona e processo para a preparação das mesmas.
BR0313207A (pt) Comprimidos de fosinopril de sódio estável ao armazenamento, processo para sua preparação e método para tratar a hipertensão
US20160310416A1 (en) Compositions containing alpha-2-adrenergic agonist components
EP0048023A2 (en) Composition for treating and preventing irritation of the eyes
JP5132015B2 (ja) 点眼剤組成物
EP0673250B1 (en) Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis